https://feeds.newsfilecorp.com/company/11604 Latest news from Rize Oncology Inc., as distributed by TMX Newsfile. en CopyRight (c) 2026, Newsfile Corp. All Rights Reserved. office@newsfilecorp.com (Newsfile Corp.) office@newsfilecorp.com (Newsfile Corp.) Wed, 11 Mar 2026 01:37:19 -0400 https://www.newsfilecorp.com/images/tmx-newsfile-wire-logo.png https://feeds.newsfilecorp.com/company/11604 https://www.newsfilecorp.com/release/273200/Rize-Oncology-Announces-Completion-of-Private-Placement-and-Resignation-of-Director Kelowna, British Columbia--(Newsfile Corp. - November 4, 2025) - Rize Oncology Inc. (OTC: RZONF) (the "Company"), a clinical-stage pharmaceutical company focused on developing innovative oncology therapeutics, is pleased to announce that on October 30, 2025 it completed a non-brokered private placement (the "Private Placement") of units of the Company (the "Units"), raising gross proceeds of C$500,000. The Private Placement consisted of the issuance of 5,000,000 Units at a price of C$0.10 per...<img src="https://api.newsfilecorp.com/newsinfo/273200/156" id="156" width="2" height="2" style="width: 1px; height: 1px;border: 0px solid;" /> Tue, 04 Nov 2025 16:27:00 -0500 en https://www.newsfilecorp.com/release/273200